Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5 (Q9904)

From Wikibase.slis.ua.edu
Revision as of 22:06, 20 May 2020 by Admin (talk | contribs) (‎Created claim: Property:P93: Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients, #quickstatements; #temporary_batch_1590010982689)
Jump to navigation Jump to search
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Sullivan RJ, et al. Nat. Med. (2019) cited as Ref 641 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Sullivan RJ
    0 references
    0 references
    2019
    0 references
    Nat. Med.
    0 references
    25
    0 references
    Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients (English)
    0 references